Aletroz Tablet
Marketer
Alemonia Life Sciences
Salt Composition
Letrozole (2.5mg)
Overview Aletroz Tablet
Aletroz tablets are indicated for breast cancer management in women who have passed menopause. This medication can be administered independently or in conjunction with other therapies, including surgical procedures or radiotherapy. In advanced breast cancer, Aletroz tablets help curb tumor metastasis. Dietary intake does not affect Aletroz tablet absorption. Adhere strictly to your physician's prescribed dosage and regimen for optimal therapeutic outcomes. Dosage and frequency are tailored to individual needs and disease progression. Your doctor will determine the appropriate dose to alleviate symptoms. Continue taking this medication as directed. Common adverse effects include hot flushes, weariness, increased perspiration, and elevated cholesterol (hypercholesterolemia). Report any concerning side effects to your doctor immediately; management strategies exist to mitigate these. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, or a history of osteoporosis. Comprehensive disclosure of all concurrent medications is crucial, as interactions may compromise efficacy or alter the medication's action. Disclose pregnancy or breastfeeding status to your physician. Pre-treatment and ongoing monitoring may include blood tests to assess vitamin D levels and bone mineral density.
Uses of Aletroz Tablet
Managing breast cancer
Major Benefits of Aletroz Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Aletroz Tablet. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Aletroz Tablet can be taken with or without food, but consistency in timing is recommended.
Common Side effects of Aletroz Tablet:
- Dizziness
- Fatigue
- Weakness
- Bone pain
- Back pain
- Night sweats
- Joint pain
- Nausea
- Osteoporosis
- Joint inflammation
- Weight gain
- Hot flushes
- Edema (swelling)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Diaphoresis
- Bone fracture
- Hypercholesterolemia (high cholesterol)
- Cough
- Shortness of breath
How to use Aletroz Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Aletroz Tablet can be administered with or without food, however, consistent timing is recommended.
How Aletroz Tablet works:
Aletroz Tablet functions as an aromatase inhibitor, reducing the body's estrogen production—a key female hormone. This lowered estrogen level can inhibit or halt the progression of certain estrogen-dependent breast cancers.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Aletroz Tablet and alcohol consumption.
PregnancyUNSAFE
Using Aletroz Tablet during pregnancy is strongly contraindicated. Pregnant women should consult their physician immediately, as research in both animal and human studies has revealed substantial risks to the fetus.
Breast feedingUNSAFE
Use of Aletroz Tablet is contraindicated while breastfeeding due to potential infant toxicity.
DrivingUNSAFE
Taking Aletroz Tablet may cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Aletroz Tablet poses no known safety concerns for individuals with kidney impairment; dose modification is not typically required. Nevertheless, data regarding its use in patients experiencing end-stage renal disease is scarce. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Aletroz Tablet cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Aletroz Tablet :
Should you forget to take your Aletroz Tablet, administer it at your earliest convenience. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Aletroz Tablet
| Label | Value |
|---|---|
| Type of Compound | Benzophenone-related compound |
| Addictive | None. |
| Medication Classification | Cancer treatments |


